| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/12/2010 | US7645610 Hepatocyte precursor cell lines |
| 01/12/2010 | US7645609 Method for controlling sialylation of proteins produced by mammalian cells |
| 01/12/2010 | US7645605 Heat-resistant nitrile hydratase |
| 01/12/2010 | US7645601 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 01/12/2010 | US7645568 Xenograft heart valves |
| 01/12/2010 | US7645458 Method for sterilizing and/or deactivating adventitious agents associated with biological materials |
| 01/12/2010 | US7645441 Compositions and methods in cancer associated with altered expression of PRLR |
| 01/12/2010 | US7645257 Intravenous device and method for removing of myoglobin from circulating blood |
| 01/12/2010 | CA2340974C Method for purifying proteins and/or biomolecule or protein complexes |
| 01/12/2010 | CA2327266C Pesticidal toxins and nucleotide sequences which encode these toxins |
| 01/12/2010 | CA2293731C Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use |
| 01/12/2010 | CA2290217C Peptides for the detection of hiv-1 group o |
| 01/12/2010 | CA2191655C Novel antibody compositions for preparing enriched human hematopoietic and tumor cell preparations |
| 01/12/2010 | CA2170412C Modified plant viruses as vectors of heterologous peptides |
| 01/07/2010 | WO2010002984A1 Recombinant dna constructs and methods for modulating expression of a target gene |
| 01/07/2010 | WO2010002862A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 01/07/2010 | WO2010002846A1 Differentiation of pluripotent stem cells |
| 01/07/2010 | WO2010002785A1 Differentiation of pluripotent stem cells |
| 01/07/2010 | WO2010002579A1 Bacteria/rna extraction device |
| 01/07/2010 | WO2010001967A1 Construction of expression system for rna polymerase derived from influenza virus, crystallization of the rna polymerase, and screening method for anti-influenza agent |
| 01/07/2010 | WO2010001951A1 Artificial kidney precursor and process for production thereof |
| 01/07/2010 | WO2010001908A1 Anti-cd27 antibody |
| 01/07/2010 | WO2010000849A2 A method for the screening of conserved secreted proteins |
| 01/07/2010 | WO2010000464A1 Prokaryotic xylose isomerase for the construction of xylose fermenting yeasts |
| 01/07/2010 | WO2010000270A1 Prodrug activation therapy for the treatment of malignant brain tumours |
| 01/07/2010 | WO2010000127A1 Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale |
| 01/07/2010 | WO2010000125A1 The key technologies of isolation, purification, freeze-drying, anabiosis of fetal liver hemopoietic stem cell and the preparation methods |
| 01/07/2010 | WO2009140452A3 Isolation of stem cell precursors and expansion in non-adherent conditions |
| 01/07/2010 | WO2009139881A3 Compositions and methods for growing embryonic stem cells |
| 01/07/2010 | WO2009137772A3 Cleavage of nanog by caspases mediates the differentiation of embryonic stem cells |
| 01/07/2010 | WO2009137624A3 Hemangio colony forming cells and non-engrafting hemangio cells |
| 01/07/2010 | WO2009132196A3 In vitro isolated gastrointestinal epithelial stem cell-like progenitor cell system |
| 01/07/2010 | WO2009120891A3 Differentiation of primate pluripotent stem cells to hematopoietic lineage cells |
| 01/07/2010 | WO2009114860A3 Activated mesenchymal stem cells for the prevention and repair of inflammatory states |
| 01/07/2010 | WO2009100384A3 Heterooligomeric serotonin/glutamate receptor complex |
| 01/07/2010 | WO2009092005A3 Methods of generating cardiomyocytes and cardiac progenitors and compositions |
| 01/07/2010 | WO2009016519A3 Bioresorbable implant |
| 01/07/2010 | WO2009016518A3 Biological mesh tissue engineering support |
| 01/07/2010 | WO2000055325A9 Plant centromeres |
| 01/07/2010 | US20100005549 Increasing uv-b tolerance in plants |
| 01/07/2010 | US20100005548 Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids |
| 01/07/2010 | US20100005546 Compositions and methods for the improvement of plants |
| 01/07/2010 | US20100005543 Toxin genes and methods for their use |
| 01/07/2010 | US20100005539 Compositions and methods for modifying gene expression using the promoter of ubiquitin conjugating protein coding gene of soybean plants |
| 01/07/2010 | US20100005536 Promoter for Introducing a Gene into a Lymphocyte or Blood Cell and Application Thereof |
| 01/07/2010 | US20100004333 Compositions and methods for treating cardiovascular disorders |
| 01/07/2010 | US20100004323 Promoter construct |
| 01/07/2010 | US20100004316 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 01/07/2010 | US20100004302 Methods for Treating Degenerative Diseases/Injuries |
| 01/07/2010 | US20100004234 Specific kinase inhibitors |
| 01/07/2010 | US20100004177 Toxin complex proteins and genes from xenorhabdus bovienii |
| 01/07/2010 | US20100004176 Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184: insecticidal proteins and methods for their use |
| 01/07/2010 | US20100004169 CCN3 peptide |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100004162 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses thereof |
| 01/07/2010 | US20100004156 Small Compounds That Correct Protein Misfolding and Uses Thereof |
| 01/07/2010 | US20100004134 Combinatorial libraries of conformationally constrained polypeptide sequences |
| 01/07/2010 | US20100003757 Methods for the production of ips cells using non-viral approach |
| 01/07/2010 | US20100003756 Methods and compositions for generation of Bax-and Bak-deficient cell lines |
| 01/07/2010 | US20100003754 Methods of differentiating stem cells |
| 01/07/2010 | US20100003753 Multivalent rna nanoparticles for delivery of active agents to a cell |
| 01/07/2010 | US20100003752 Liver progenitor cells |
| 01/07/2010 | US20100003751 Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns |
| 01/07/2010 | US20100003750 Making encoded ghost cells for multiplexed detection of anti-red cell alloantibodies |
| 01/07/2010 | US20100003749 Enriched Pancreatic Stem Cell and Progenitor Cell, Populations, and Methods For Identifying, Isolating and Enriching For Such Populations |
| 01/07/2010 | US20100003748 Compositions, systems, and methods for stabilization of a cell and/or macromolecule |
| 01/07/2010 | US20100003747 Cultured xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
| 01/07/2010 | US20100003721 Human interferon-beta mutein |
| 01/07/2010 | US20100003719 Trimerising Module |
| 01/07/2010 | US20100003663 Composition For Preserving Reproductive Cells And Method Of Using |
| 01/07/2010 | US20100003307 Composition and use of rar antagonists for promoting chondrogenesis |
| 01/07/2010 | US20100003299 RNAi Methods and Compositions for Stimulating Proliferation of Cells with Adherent Functions |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003273 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/07/2010 | US20100003272 Method for Expanding Monocytes |
| 01/07/2010 | US20100003271 Nitric oxide increases switching of t cells into t regulatory cells |
| 01/07/2010 | US20100003270 Whole blood cultures comprising stimulated immune cells, and use thereof as medicaments |
| 01/07/2010 | US20100003266 Targeted immune conjugates |
| 01/07/2010 | US20100003265 Isolation, expansion and uses of tumor stem cells |
| 01/07/2010 | US20100003262 Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 01/07/2010 | US20100003261 agonist anti-trk-c monoclonal antibodies |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 01/07/2010 | US20100003244 Agents which bind to epitopes of glycoprotein vi |
| 01/07/2010 | US20100003242 antibody that binds sphingosine-1-phosphate (S1P); used for detection of S1P or for treatment of diseases and conditions associated with S1P |
| 01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 01/07/2010 | US20100003232 Insulin-degrading enzyme mutants and methods of use |
| 01/07/2010 | US20100003223 Method for the production of multicomponent stem cells, relative kits and uses in the medical field |
| 01/07/2010 | US20100003219 Methods to Increase Transgene Expression From Bacterial-Based Delivery Systems by Co-Expressing Suppressors of the Eukaryotic Type I Interferon Response |
| 01/07/2010 | US20100000152 Method for producing biomineral-containin substance and organic hydroponics method |
| 01/07/2010 | CA2729765A1 Artificial kidney precursor and process for production thereof |
| 01/07/2010 | CA2729734A1 Differentiation of pluripotent stem cells |
| 01/07/2010 | CA2729731A1 Bacteria/rna extraction device |
| 01/07/2010 | CA2729713A1 Recombinant dna constructs and methods for modulating expression of a target gene |
| 01/07/2010 | CA2729567A1 Anti-cd27 antibody |
| 01/07/2010 | CA2729121A1 Differentiation of pluripotent stem cells |
| 01/07/2010 | CA2728927A1 Antigen screening system |
| 01/07/2010 | CA2728682A1 Prokaryotic xylose isomerase for the construction of xylose fermenting yeasts |
| 01/06/2010 | EP2141240A2 Plants that can tolerate herbicides by bypassing the metabolic route |
| 01/06/2010 | EP2141239A1 Dominant gene suppression transgenes and methods of using same |